Lactoferrin inducible monocyte cytotoxicity defective in esterase deficient monocytes.
We recently demonstrated a higher incidence of monocyte esterase deficiency in patients with lymphoproliferative neoplasia and gastrointestinal carcinoma than in the normal population. Using lactoferrin to stimulate monocyte cytotoxicity we have now compared the abilities of esterase positive and esterase deficient monocytes to lyse K562 cells. The esterase deficient monocytes were from normal subjects whose monocytes have consistently failed to show cytochemical esterase staining over 30-72 months and which lack specific monocyte isoenzymes. The esterase positive monocytes were from age and sex matched control subjects. Esterase positive monocytes responded to lactoferrin stimulation by a five-fold increase in cytotoxicity whereas deficient monocytes failed to produce any response. These results indicate a possible defect in cytotoxicity of esterase deficient monocytes and together with the epidemiological findings suggest a link between monocyte esterase deficiency and neoplasia.
McCormick
J A
JA
Department of Haematology, Belfast City Hospital, Northern Ireland.
Markey
G M
GM
Morris
T C
TC
Auld
P W
PW
Alexander
H D
HD
D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic / Q000187:drug effects / Q000502:physiology*; D004950:Esterases / Q000172:deficiency*; D006801:Humans; D007781:Lactoferrin / Q000494:pharmacology; D008214:Lymphocytes / Q000276:immunology; D009000:Monocytes / Q000201:enzymology* / Q000276:immunology; D009369:Neoplasms / Q000201:enzymology
D004950:Esterases; D007781:Lactoferrin